Study of ZIO-201 in Advanced Sarcoma

Phase 1

Completed

• Conditions: Advanced Sarcoma
• Interventions: Drug: ZIO-201

• Registration Number: NCT00439686
• Lead Sponsor: Alaunos Therapeutics

Brief Summary

The study of safety of Isophosphoramide Mustard (IPM) in the treatment of advanced sarcoma.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-02
• Study First Submitted: 2007-02-22
• Study First Submitted QC: 2007-02-22
• Study First Posted: 2007-02-26
• Primary Completion: 2008-06
• Study Completion: 2013-12
• Status Verified: 2014-01
• Last Update Submitted: 2014-01-29
• Last Update Posted: 2014-01-31

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 53

Inclusion Criteria

Not provided

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Single Arm	ZIO-201	-

Primary Outcome Measures

Name	Time	Method
toxicities	6 months

Secondary Outcome Measures

Name	Time	Method
pharmacokinetics	6 months